Can TIVC's EPS recover in the next quarter?

**TIVC's EPS may not recover in the next quarter based on current information.** Here's the analysis to support this conclusion:

1. **Current Financial Performance**: Tivic Health Systems, Inc. Common Stock (TIVC) has reported a revenue of $0.8 million for the latest report period ending on December 31, 2024, which is a decrease from $1.2 million in 2023. The company's gross profit has also significantly decreased, with a reported $2 thousand in 2024 compared to $287 thousand in the previous year. This indicates a challenging financial environment for the company.

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|TIVC|TIVC.O|Tivic Health|2024 Q1|90.39923954372624|-1.01|186|
|TIVC|TIVC.O|Tivic Health|2024 Q2|95.53072625698323|-0.32|186|
|TIVC|TIVC.O|Tivic Health|2024 Q3|84.45945945945947|-0.23|186|

2. **Analyst Expectations**: The upcoming earnings date for TIVC is May 19, 2025, which is derived from an algorithm. There is no available data on EPS expectations for this quarter. However, given the company's recent performance and the absence of EPS data for the next quarter, it is unclear if EPS will recover in the near term.
3. **Strategic Initiatives**: Tivic Health Systems is undergoing a significant transformation, including the acquisition of a promising drug candidate and a strategic shift towards diversified therapeutics. While these initiatives suggest potential for future growth, they may not immediately reverse the trend of declining EPS.
4. **Cash Position and Financial Stability**: The company has reported a net loss reduction but still has a negative EPS. Tivic Health Systems has a cash and equivalents total of $2 million as of December 31, 2024, which is a decrease from $3.4 million at the end of 2023. This reduction in cash reserves could limit the company's ability to invest in growth or recover from a loss period.

In conclusion, while Tivic Health Systems is undergoing strategic changes that could potentially lead to future growth, the current financial data and the absence of EPS projections for the next quarter suggest that EPS may not recover in the immediate term. The company's focus on transformation and diversification are positive signs for long-term potential, but they may not swiftly translate to an EPS recovery in the next quarter.